Verify any claim · lenz.io
Claim analyzed
Science“Green fluorescent protein (GFP) mice were first developed at Osaka University in Japan.”
The conclusion
The scientific record consistently credits Osaka University as the origin of the first GFP transgenic mice. A 1995 paper by Ikawa, Okabe, and colleagues at Osaka University is recognized by independent field reviews—including a Nature Methods history of fluorescent protein technology—as the first report of GFP-expressing transgenic mice. No credible evidence of an earlier GFP mouse from another institution exists in the available literature. The term "GFP mice" broadly encompasses many later lines, but Osaka's priority for the foundational work is well established.
Based on 29 sources: 13 supporting, 5 refuting, 11 neutral.
Caveats
- 'GFP mice' is an umbrella term covering many transgenic reporter lines; Osaka University's documented priority applies specifically to the first reported ubiquitous GFP-expressing transgenic mice (1995), not every subsequent GFP mouse line.
- Several supporting sources are Osaka-affiliated institutional repositories, which carry inherent self-reporting bias; the claim's strength rests primarily on independent reviews such as the Nature Methods synthesis.
- No source in the evidence pool conducts an exhaustive global survey ruling out all possible unpublished or obscure earlier GFP mouse work, though no competing claim has surfaced in the literature.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
Institution: Genome Information Research Center with Research Institute for Microbial Diseases, Osaka University. Developer: Masaru Okabe. Depositor: Masaru Okabe. GFP mice is transgenic mice expressing Green Fluorescent Protein gene (act-EGFP) derived from the jellyfish Aequorea victoria in whole body.
The family of proteins homologous to the green fluorescent protein (GFP) from Aequorea victoria exhibits striking diversity of features.
The authors succeeded in creating the world's first transgenic mice expressing GFP. They demonstrated that GFP functions as a reporter or marker for gene expression even at the individual level in mammals.
Transgenic mice expressing GFP and modified GFP were created, showing that they are useful as reporters for gene expression at the mammalian individual level. This established green fluorescent mice.
GFP-expressing transgenic mice were first reported in 1995 by Ikawa and colleagues at Osaka University, utilizing the chicken β-actin promoter to drive ubiquitous expression of wtGFP, though initial fluorescence was weak due to poor codon usage.
Transgenic mice were produced using the GFP coding sequence, ligated with the chicken beta-actin promoter. Faculty of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565, Japan. Authors: Masahito Ikawa, Katsuya Kominami, Yasuhide Yoshimura, Keiichi Tanaka, Yoshitake Nishimune, Masaru Okabe. Affiliations: Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565, Japan. Published 1995.
Green fluorescent protein (GFP) transgenic (GFP+) mice express GFP in most tissues except erythrocytes and hair. Affiliation: Department of Immunology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Japan. Authors include M Ikawa, M Okabe. Published 1999.
Historical note: Ubiquitous GFP transgenic mice were first generated by Okabe et al. (1995) at Osaka University using actin promoter-driven GFP. This is referenced in reviews as the foundational whole-body GFP mouse line.
We were the first in the world to incorporate the GFP gene from glowing jellyfish into fluorescent mice.
Origin: Osaka University Genetic Information Experimental Center. Establisher: Professor Masaru Okabe. This is a transgenic mouse expressing Green Fluorescent Protein (act-EGFP) derived from Aequorea victoria jellyfish throughout the body.
Since the discovery and cloning of the first fluorescent protein (FP), wild type green fluorescent protein (wtGFP) from the bioluminescent jellyfish Aequorea victoria, and the subsequent creation of spectral variants, FPs have become indispensable for imaging cellular differentiation and function. The most commonly used approaches for generation of fluorescent reporter mice are microinjection of DNA into a fertilized egg.
GFP transgenic mice were generated as early as 1995, but brighter variants were needed for better imaging; the first practical GFP mice used enhanced GFP (EGFP) developed later.
In the present study transgenic mice expressing green fluorescent protein (GFP) in the germ cell line were generated using the same Oct-4 genomic fragments. This is a later study (received 1999) building on prior GFP transgenic work, but does not claim to be the first overall GFP mice.
This transgenic mouse is useful for visualizing dopamine neurons to study the physiology and pathogenesis of dopamine neurons. This is a different GFP transgenic line (TH-GFP) developed later at RIKEN, not claiming to be the first GFP mice.
Green Mouse, which expresses GFP throughout the body, was created using the CAG promoter.
GFP gene: The gene encoding green fluorescent protein (GFP) discovered by Osamu Shimomura, who won the Nobel Prize in Chemistry in 2008. Introducing the GFP gene into animals allows visualization of tissues and cells that fluoresce green.
We have developed efficient new gene modification techniques and created new model animals by applying genome editing technology to mouse and rat embryos.
These transgenic mice express nuclear-localized, photoactivatable GFP in neurons, and may be useful to rapidly mark and follow selected populations of neurons in living tissue with single cell resolution using two-photon excitation.
GFP is a fluorescent protein that was first isolated from a jellyfish called Aequorea victoria in 1961. In 2008 the Nobel Prize in Chemistry was awarded to three scientists 'for the discovery and development of the green fluorescent protein, GFP.'
GFP was discovered by Osamu Shimomura in 1962 while investigating the natural bioluminescence of the jellyfish Aequorea victoria. Then, just two years later [after 1992 cloning], Chalfie et al. expressed GFP in Escherichia coli and Caenorhabditis elegans.
Did you know that scientists can use jellyfish proteins to track the activity of genes? Join us to learn how 3 scientists were awarded a Nobel Prize.
Roger Tsien describes fluorescent proteins, covers the history of GFP, how GFP folds and becomes fluorescent, and how GFP has been altered to produce different colors.
In 1994, Prasher’s collaborator Martin Chalfie expressed GFP in exogenous organisms (E. coli, and later C. elegans) for the first time.
The first experiment of this type was done by my wife, Tulle Hazelrigg, who made the first GFP fusion protein and watched its movement in the developing fruit fly.
Prasher set out to find the GFP gene, and then clone it, by constructing a gene library from Aequorea jellyfish tissue. In a 1962 paper, Shimomura described his discovery of aequorin in great detail, but only mentioned the 'green protein' in a footnote.
The interest of man in fluorescent proteins can be traced back to the first century A.D. when the roman natural philosopher Pliny the Elder described a glowing jellyfish.
Green Mouse (GFP gene glowing mouse) provided by Osaka University Research Institute for Microbial Diseases, Genetic Information Experimental Center.
The first GFP transgenic mice expressing GFP ubiquitously were developed by Masaru Okabe and colleagues at Osaka University in 1995, as detailed in their publication in Development Growth & Differentiation. This is widely recognized in scientific literature as the pioneering work for whole-body GFP mice, predating specialized lines like germline or neuron-specific ones.
Researchers created transgenic rats with bright red fluorescent skin under green excitation light. Nicknamed 'FLAME', the rats will be used for research.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
Expert review
How each expert evaluated the evidence and arguments
Expert 1 — The Logic Examiner
The evidence chain is: a 1995 primary paper from Osaka University authors reports producing GFP transgenic mice (Source 6), and multiple secondary/summary sources explicitly state these were the first GFP-expressing transgenic mice and attribute that first report/generation to Ikawa/Okabe at Osaka University (Sources 5, 8), with institutional/registry pages aligning on Osaka provenance for the canonical whole-body GFP mouse line (Sources 1, 3, 10). The opponent's objections largely target whether the corpus “rules out” unknown earlier work (argument from silence) and conflate earlier GFP expression in non-mouse organisms with mouse priority (irrelevant conclusion), but given the direct “first reported/generated” statements in independent reviews (5, 8) plus the contemporaneous 1995 publication (6), the claim that GFP mice were first developed at Osaka University is logically supported and best judged true in the intended sense (first GFP transgenic mice).
Expert 2 — The Context Analyst
The claim omits that “GFP mice” can mean many different transgenic reporter lines, and the strongest evidence supports priority for the first reported GFP-expressing transgenic mice (ubiquitous/whole-body) by an Osaka University team in 1995 rather than proving Osaka originated every later GFP mouse line or that no unpublished/obscure earlier mouse existed (Sources 5, 6, 8, 12). With that context restored, the overall impression—Osaka University is credited in the scientific record as the first to develop/report GFP transgenic mice—is accurate, so the claim is mostly true rather than perfectly complete (Sources 5, 6, 3).
Expert 3 — The Source Auditor
The most reliable independent synthesis in the pool, Source 5 (Nature Methods), explicitly states that GFP-expressing transgenic mice were first reported in 1995 by Ikawa et al. at Osaka University, and this is consistent with the primary bibliographic record in Source 6 (PubMed listing the 1995 paper with Osaka University affiliations) plus high-authority registry provenance pages Source 1/10 (NIBN/JCRB) that attribute the foundational GFP mouse line's development/establishment to Osaka University/Okabe. The nominal “refuting” sources (e.g., Source 20 Jackson ImmunoResearch; Source 23 Addgene blog; Source 19 DNALC) discuss discovery/first expression of GFP in other organisms rather than mice and therefore do not contradict the mouse-specific priority claim, so the best trustworthy evidence supports the claim that GFP mice were first developed at Osaka University.
Expert summary
The arguments
Two AI advocates debated this claim using the research gathered.
Argument for
Multiple highly authoritative and independent sources converge on the same conclusion: GFP mice were first developed at Osaka University in Japan — specifically, Source 5 (Nature Methods) explicitly states that "GFP-expressing transgenic mice were first reported in 1995 by Ikawa and colleagues at Osaka University," Source 6 (PubMed) confirms the 1995 publication by Ikawa, Okabe, and colleagues affiliated with Osaka University, and Source 3 (Osaka University Institutional Repository) declares they "succeeded in creating the world's first transgenic mice expressing GFP." This is further corroborated by Source 1 (JCRB Laboratory Animal Resource Bank at NIBN), Source 8 (Nature), Source 9 (Osaka University Graduate School of Medicine), and Source 10 (NIBN), all of which independently attribute the creation of the first GFP mice to Masaru Okabe and his team at Osaka University, leaving no credible competing claim in the evidence.
You're treating repetition as proof: the only genuinely independent, field-level synthesis you cite is Source 5 (Nature Methods), and it says “first reported” in 1995—not “first developed” at Osaka—while the rest of your stack is either Osaka self-archiving (Source 3, Source 9) or mouse-line registry provenance that merely records who deposited/established a particular Osaka-derived strain (Source 1, Source 10), which cannot rule out earlier development elsewhere. And your “no credible competing claim” is an argument from silence: none of your sources actually surveys the global literature to exclude prior GFP-mouse work, so your leap from “these Osaka papers/registries say we did it” to “therefore Osaka was first” is exactly the missing-negative-evidence problem my opening flagged (Source 6 vs. the broader context in Source 20 and Source 23 showing key GFP milestones happened outside Osaka).
Argument against
The motion overreaches: the brief's strongest primary evidence (PubMed 1995 paper, Source 6) shows GFP transgenic mice were produced by an author team with multiple Osaka University affiliations, but it does not establish that Osaka University was where GFP mice were “first developed” globally, only that this particular line was made there. Moreover, several items in the brief that are framed as “refutations” (e.g., Source 20 and Source 23) document key first expressions of GFP in other organisms prior to any mouse work, undercutting the claim's implied priority narrative and showing the brief lacks any independent, non-Osaka proof that no other lab developed GFP mice earlier.
Your first point commits a classic moving-the-goalposts fallacy: Source 5 (Nature Methods) does not merely show "a particular line was made" at Osaka — it explicitly states GFP-expressing transgenic mice were "first reported" by Ikawa and colleagues at Osaka University, and Source 3 (Osaka University Institutional Repository) independently declares they "succeeded in creating the world's first transgenic mice expressing GFP," which together constitute direct, unambiguous global priority claims from highly authoritative sources. Your second point is a red herring: Sources 20 and 23 discuss GFP expression in bacteria and C. elegans, which are entirely different organisms from mice, so their existence does nothing to undercut Osaka University's priority for GFP mice specifically — the motion's actual claim — and you have produced zero evidence of any rival lab developing GFP mice before 1995.